Appraisals - ASAR & FAR

25/07/2019

Final Recommendation: ipilimumab (Yervoy) 3604

25/07/2019

Final Recommendation: lanreotide (Somatuline Autogel) 1988

25/07/2019

Final Recommendation: octreotide (Sandostatin LAR) 3732

25/07/2019

Final Recommendation: levonorgestrel (Kyleena) 3582

12/05/2022

Final Recommendation: cariprazine (Reagila) 5032

12/05/2022

Final Recommendation: teriflunomide (Aubagio) 4033

12/05/2022

Final Recommendation: mercaptamine bitarate (Procysbi) 4804

16/03/2022

Final Recommendation: adalimumab (Humira) 4526

19/08/2019

Final Recommendation: tapentadol prolonged release (PalexiaSR) 651

23/02/2022

Final Recommendation: clostridium botulinum (Dysport) 2626

23/02/2022

Final Recommendation: inclisiran (Leqvio) 3746

23/02/2022

Final Recommendation: buprenorphine (Sixmo) 4262

23/02/2022

Final Recommendation: tirbanibulin (Klisyri) 4076

25/07/2019

Final Recommendation: dalbavancin (Xydalba) 2001

25/07/2019

Final Recommendation: selexipag (Uptravi) 700

25/07/2019

Final Recommendation: ranibizumab (Lucentis) 3233

25/07/2019

Final Recommendation: telotristat ethyl (Xermelo) 2037

25/07/2019

Final Recommendation: ciprofloxacin (Cetraxal) 1343

04/01/2022

Final Recommendation: icatibant acetate (Firazyr) 3293

04/01/2022

Final Recommendation: dabigatran etexilate (Pradaxa) 2293